Ajay Kumar Dewan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ajay Kumar Dewan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Abhinav Dewan
Rajiv Gandhi Canc Inst & Res Ctr, Dept Radiat Oncol, New Delhi, India
1 shared publication - Charanjeet Kaur
Department of Anaesthesiology and Critical Care, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Delhi, India
1 shared publication - Himanshu Mahesh Shukla
Faculty of Management, Symbiosis Institute of Business Management, Nagpur, Symbiosis International (Deemed University), Nagpur, India
1 shared publication - Nikhil Bhasin
Department of Anaesthesiology and Critical Care, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Delhi, India
1 shared publication - Rajan Arora
Rajiv Gandhi Cancer Institute and Research Centre New Delhi India
1 shared publication - Rajiv Chawla
Department of Anaesthesiology and Critical Care, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Delhi, India
1 shared publication
Latest Publications
- Open Access
- 10 July 2025
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 69 (8) , 824-831
Comparison of the efficacy of Enhanced Recovery After Surgery (ERAS) protocol tailor-made for head and neck free flap oncosurgery with conventional perioperative care: A randomised clinical trial
Background and Aims: Technological advances, accumulated experience, and evidence have made free-flap reconstruction [using the anterolateral thigh flap (ALT) and free fibular flap (FF)] for head and neck oncosurgical defects a routine procedure. This study aimed to assess the impact on recovery after head and neck oncosurgery by preoperative optimisation, intraoperative stress minimisation, and postoperative protocolised normalisation. Methods: This randomised study included 60 adult patients undergoing head and neck oncosurgery with ALT/FF reconstruction, allocated to either the Enhanced Recovery After Surgery (ERAS) group (Group E) or the conventional care group (Group C). Our primary outcome measures were the length of hospital stay (LOS) and time to Return to Intended Oncologic Therapy (RIOT). Surgical intensive care unit (SICU) stay, serum lactate, creatinine, and opioid consumption comprised the secondary outcome measures. An independent sample t -test or Welch test was performed for continuous variables, and a Chi-square test was used for categorical variables. Results: Mean LOS and time to RIOT [9.97 (standard deviation (SD): 2.19) and 34.6 (SD: 9.22) days] were significantly shorter in Group E versus Group C (10.97 (SD: 1.45) and 43.8 (SD: 20.89) days) (mean difference (MD): 1, 95% confidence interval (CI): 0.04, 1.96, P = 0.042, and MD: 9.2, 95% CI: 0.77, 17.63, P = 0.033, respectively). Mean pre-incisional, post-resection, and postoperative lactate levels were significantly lower in Group E versus Group C ( P < 0.0001). Serum creatinine levels on the morning of surgery were significantly lower in Group E ( P = 0.0225). Conclusion: At least 90% compliance with the described 15-element ERAS protocol reduces LOS and time to RIOT in head-neck oncosurgery patients with free-flap reconstruction.
- 10 July 2025
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 69 (8) , 824-831
Open AccessComparison of the efficacy of Enhanced Recovery After Surgery (ERAS) protocol tailor-made for head and neck free flap oncosurgery with conventional perioperative care: A randomised clinical trial
Background and Aims: Technological advances, accumulated experience, and evidence have made free-flap reconstruction [using the anterolateral thigh flap (ALT) and free fibular flap (FF)] for head and neck oncosurgical defects a routine procedure. This study aimed to assess the impact on recovery after head and neck oncosurgery by preoperative optimisation, intraoperative stress minimisation, and postoperative protocolised normalisation. Methods: This randomised study included 60 adult patients undergoing head and neck oncosurgery with ALT/FF reconstruction, allocated to either the Enhanced Recovery After Surgery (ERAS) group (Group E) or the conventional care group (Group C). Our primary outcome measures were the length of hospital stay (LOS) and time to Return to Intended Oncologic Therapy (RIOT). Surgical intensive care unit (SICU) stay, serum lactate, creatinine, and opioid consumption comprised the secondary outcome measures. An independent sample t -test or Welch test was performed for continuous variables, and a Chi-square test was used for categorical variables. Results: Mean LOS and time to RIOT [9.97 (standard deviation (SD): 2.19) and 34.6 (SD: 9.22) days] were significantly shorter in Group E versus Group C (10.97 (SD: 1.45) and 43.8 (SD: 20.89) days) (mean difference (MD): 1, 95% confidence interval (CI): 0.04, 1.96, P = 0.042, and MD: 9.2, 95% CI: 0.77, 17.63, P = 0.033, respectively). Mean pre-incisional, post-resection, and postoperative lactate levels were significantly lower in Group E versus Group C ( P < 0.0001). Serum creatinine levels on the morning of surgery were significantly lower in Group E ( P = 0.0225). Conclusion: At least 90% compliance with the described 15-element ERAS protocol reduces LOS and time to RIOT in head-neck oncosurgery patients with free-flap reconstruction.
- Open Access
- 3 December 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (17) , 7627-7632
Salvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience
Salvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience Salvage TORS;recurrent or residual head neck cancer;feasability;safety; Background: The present study was conducted to evaluate the technical feasibility, safety and adequacy of surgical margins with salvage transoral robotic surgery (TORS) for recurrent or residual head and neck squamous cell carcinoma patients. Materials and Methods: Thirty patients who underwent salvage TORS using the 'DaVinci' robot were enrolled in the study and data related to their surgical time, complications and functional outcome were recorded. Results: The feasibility of salvage TORS in our study was observed to be 100%. Positive margins were encountered in only 6.7% of patients. Mean blood loss was 23.3 ml with no patient requiring blood transfusion. Postoperative complications in the form of primary haemorrhage requiring active surgical intervention occurred in 13.3%. Oral feeding could be started as early as the 3rd postoperative day in a few patients, with nasogastric tubes being removed on the 12th postoperative day. Long term gastrostomy tube dependency was seen in 10% cases. Median survival of patients was 19 months. Conclusions: Salvage TORS is a safe, effective and feasible option in the management of treatment failure cases. It offers an alternative surgical approach with unexpected benefits in terms of tracheostomy tube use, Ryle's tube and gastrostomy dependence.
- 3 December 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (17) , 7627-7632
Open AccessSalvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience
Salvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience Salvage TORS;recurrent or residual head neck cancer;feasability;safety; Background: The present study was conducted to evaluate the technical feasibility, safety and adequacy of surgical margins with salvage transoral robotic surgery (TORS) for recurrent or residual head and neck squamous cell carcinoma patients. Materials and Methods: Thirty patients who underwent salvage TORS using the 'DaVinci' robot were enrolled in the study and data related to their surgical time, complications and functional outcome were recorded. Results: The feasibility of salvage TORS in our study was observed to be 100%. Positive margins were encountered in only 6.7% of patients. Mean blood loss was 23.3 ml with no patient requiring blood transfusion. Postoperative complications in the form of primary haemorrhage requiring active surgical intervention occurred in 13.3%. Oral feeding could be started as early as the 3rd postoperative day in a few patients, with nasogastric tubes being removed on the 12th postoperative day. Long term gastrostomy tube dependency was seen in 10% cases. Median survival of patients was 19 months. Conclusions: Salvage TORS is a safe, effective and feasible option in the management of treatment failure cases. It offers an alternative surgical approach with unexpected benefits in terms of tracheostomy tube use, Ryle's tube and gastrostomy dependence.